Key terms
About ACHV
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ACHV news
Apr 16
4:25pm ET
Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration
Apr 16
4:15pm ET
Achieve Life Sciences initiated with a Buy at JonesResearch
Apr 01
9:00am ET
Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)
Apr 01
6:50am ET
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT)
Mar 28
4:08pm ET
Achieve Life Sciences reports Q4 EPS (26c), consensus (31c)
Mar 28
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 28, 2024
Mar 25
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
Mar 20
8:07am ET
Achieve Life Sciences announces data from cytisinicline ORCA program
Mar 05
9:00am ET
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
Mar 05
8:41am ET
Achieve Life Sciences price target lowered to $11 from $19 at Lake Street
Feb 29
4:52pm ET
Achieve Life Sciences Raises Funds for Clinical Trials
Feb 29
2:15pm ET
Buy Rating for Achieve Life Sciences on Cytisinicline’s Promising Future and Solid Financials
Feb 29
8:29am ET
Achieve Life reaches agreement with FDA on cytisinicline data requirements
Feb 29
8:22am ET
Achieve Life Sciences sells 13M shares at $4.585 in registered direct offering
No recent press releases are available for ACHV
ACHV Financials
Key terms
Ad Feedback
ACHV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ACHV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range